Drug Trial Radar · NCT00642980
Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis
Last checked: Nov 19, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,105
Actual
Start
Apr 2006
Primary completion
Jun 2011
Study completion Jun 2011
Sponsor
- Lead sponsor
- University Hospital, LilleAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Pfizer
- First posted
- Mar 25, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Background. Anomalies of the vaginal flora (bacterial vaginosis, BV) are associated with an increased risk of late abortions and preterm birth. Studies of antibiotic treatment of BV to reduce the risk of prematurity have not found a statistically significant diminution of risk (\<= 32 wks: OR=0.49 \[0.05-5.1\], \< 37 wks: OR=0.83 \[0.59-1.17\]).A partial explanation of these findings is that some of these treatment were administered vaginally, most often during the second or third trimester Aim: To reduce the frequency of late abortions and very preterm birth by prescribing clindamycin vs placebo to patients diagnosed with BV before 13 weeks.
Conditions
- Pregnancy
Interventions
ClindamycinDrug
300 mg capsules (per os) Intervention= 2 capsules/d during 4 days: three times a month apart
PlaceboDrug
Double blinded capsules(per os) Intervention= 2 capsules/d during 4 days: three times a month apart
ClindamycinDrug
300 mg capsules (per os) Intervention= 2 capsules/d during 4 days: one time and then, after one month placebo capsules 2 capsules/d during 4 days: two times a month apart
Primary outcomes
What the sponsor says the trial is designed to measure.
- Premature delivery (16 to 32 weeks of gestation)Time frame: At delivery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hopital Jeanne de Flandre
Lille, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.